Discrepancy in MALDI-TOF MS identification of uncommon Gram-negative bacteria from lower respiratory secretions in patients with cystic fibrosis

Infection and Drug Resistance

Volumn 8, Issue , 2015, Pages 83-88

  AbdulWahab, Atqah ^a,b   Taj Aldeen, Saad J ^a   Ibrahim, Emad Bashir ^a   Talaq, Eman ^c   Abu Madi, Marawan ^c   Fotedar, Rashmi ^d  

^a HAMAD MEDICAL CORPORATION   (Qatar)

^b WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^c Qatar University   (Qatar)

^d Ministry of Environment   (Qatar)

Author keywords

Bacteria; Cystic fibrosis; MALDI TOF MS; Molecular identification; Respiratory secretions

Indexed keywords

ACHROMOBACTER XYLOSOXIDANS; ADOLESCENT; ADULT; ARTICLE; BACTERIUM IDENTIFICATION; CHRYSEOBACTERIUM GLEUM; CLINICAL ARTICLE; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; ENTEROBACTER CLOACAE; FEMALE; GENE SEQUENCE; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAPHROHAEMOLYTICUS; HUMAN; INTERMETHOD COMPARISON; LOWER RESPIRATORY TRACT; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PHENOTYPE; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RELIABILITY; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PYOGENES;

EID: 84929397471     PISSN: 11786973     EISSN: 11786973     Source Type: Journal    
DOI: 10.2147/IDR.S80341     Document Type: Article

References (27)

1. Ratjen F, Doring G. Cystic fibrosis. Lancet. 2003;361(9358):681-689.
2. Cystic Fibrosis Foundation. 2012 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation Patient Registry; 2013.
3. Lambiase A, Raia V, Del Pezzo M, Sepe A, Carnovale V, Rossano F. Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect Dis. 2006;6:4.
4. Coenye T, Vandamme P, LiPuma JJ. Infection by Ralstonia species in cystic fibrosis patients: identification of Ralstonia pickettii and R. mannitolilytica by polymerase chain reaction. Emerg Infect Dis. 2002;8(1):692-696.
5. Segonds C, Paute S, Chabanon G. Use of amplified ribosomal DNA restriction analysis for identification of Ralstonia and Pandoraea species: interest in determination of the respiratory bacterial flora in patients with cystic fibrosis. J Clin Microbiol. 2003;41(7):3415-3418.
6. Wellinghausen N, Essig A, Sommerburg O. Inquilinus limosus in patients with cystic fibrosis, Germany. Emerg Infect Dis. 2005;11(3): 457-459.
7. LiPuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev. 2010;23(2):299-323.
8. Bosshard PP, Zbinden R, Abels S, Böddinghaus B, Altwegg M, Böttger EC. 16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory. J Clin Microbiol. 2006;44(4):1359-1366.
9. Ferroni A, Sermet-Gaudelus I, Abachin E, et al. Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center. J Clin Microbiol. 2002;40(10):3793-3797.
10. Seng P, Drancourt M, Gouriet F, et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis. 2009;49(4):543-551.
11. Sandrin TR, Goldstein JE, Schumaker S. MALDI TOF MS profiling of bacteria at the strain level: a review. Mass Spectrom Rev. 2013;32(3): 188-217.
12. Fernández-Olmos A, García-Castillo M, Morosini MI, Lamas A, Máiz L, Cantón R. MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients. J Cyst Fibros. 2012;11(1):59-62.
13. Gaillot O, Blondiaux N, Loiez C, et al. Cost-effectiveness of switching to matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine bacterial identification. J Clin Microbiol. 2011; 49(12):4412.
14. Desai AP, Stanley T, Atuan M, et al. Use of matrix assisted laser desorption ionisation-time of flight mass spectrometry in a paediatric clinical laboratory for identification of bacteria commonly isolated from cystic fibrosis patients. J Clin Pathol. 2012;65(9):835-838.
15. Bizzini A, Durussel C, Bille J, Greub G, Prod'hom G. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol. 2010;48(5): 1549-1554.
16. McElvania Tekippe E, Shuey S, Winkler DW, Butler MA, Burnham CA. Optimizing identification of clinically relevant Gram-positive organisms by use of the Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry system. J Clinc Microbiol. 2013;51(5):1421-1427.
17. Murphy TF, Brauer AL, Sethi S, Kilian M, Cai X, Lesse AJ. Haemophilus haemolyticus: a human respiratory tract commensal to be distinguished from Haemophilus influenza. J Infect Dis. 2007;195(1):81-89.
18. Nørskov-Lauritsen N. Classification, identification, and clinical significance of Haemophilus and Aggregatibacter species with host specificity for humans. Clin Microbiol Rev. 2014;27(2):214-240.
19. Mukundan D, Ecevit Z, Patel M, Marrs CF, Gilsdorf JR. Pharyngeal colonization dynamics of Haemophilus influenzae and Haemophilus haemolyticus in healthy adult carriers. J Clinc Microbiol. 2007;45(10): 3207-3217.
20. Anderson R, Wang X, Briere EC, et al. Haemophilus haemolyticus isolates causing clinical disease. J Clin Microbiol. 2012;50(7):2462-2465.
21. Hedegaard J, Okkels H, Bruun B, Kilian M, Mortensen KK, Nørskov-Lauritsen N. Phylogeny of the genus Haemophilus as determined by comparison of partial infB sequences. Microbiology. 2001;147(pt 9): 2599-2609.
22. Frickmann H, Christner M, Donat M, et al. Rapid discrimination of Haemophilus influenzae, H. parainfluenzae, and H. haemolyticus by fluorescence in situ hybridization (FISH) and two matrix-assisted laser-desorption-ionization time-of-flight mass spectrometry (MALDI-TOF-MS) platforms. PLoS One. 2013;8(4):e63222.
23. Homem de Mello de Souza HA, Dalla-Costa LM, Vicenzi FJ, et al. MALDI-TOF: a useful tool for laboratory identification of uncommon glucose non-fermenting Gram-negative bacteria associated with cystic fibrosis. J Med Microbiol. 2014;63(pt 9):1148-1153.
24. Coenye T, Goris J, Spilker T, Vandamme P, LiPuma JJ. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J Clin Microbiol. 2002;40(6):2062-2069.
25. Bellais S, Naas T, Nordmann P. Genetic and biochemical characterization of CGB-1, an Ambler class B carbapenem-hydrolyzing β-lactamase from Chryseobacterium gleum. Antimicrob Agents Chemother. 2002;46: 2791-2796.
26. Cystic Fibrosis Trust. Laboratory Standards for Processing Microbiological Samples from People with Cystic Fibrosis: Report of the UK Cystic Fibrosis Trust Microbiology Laboratory Standards Working Group. 2010. Available from https://www.cysticfibrosis.org.uk/media/82034/CD_Laboratory_Standards_Sep_10. pdf.
27. Alby K, Gilligan PH, Miller MB. Comparison of matrix-assisted laser desorption-time of flight (MALDI-TOF) mass spectrometry platforms for the identification of Gram-negative rods from patients with cystic fibrosis. J Clin Microbiol. 2013;51(11):3852-3854.